245 related articles for article (PubMed ID: 8388208)
1. Human immunodeficiency virus counseling, testing, referral, and partner notification services. A cost-benefit analysis.
Holtgrave DR; Valdiserri RO; Gerber AR; Hinman AR
Arch Intern Med; 1993 May; 153(10):1225-30. PubMed ID: 8388208
[TBL] [Abstract][Full Text] [Related]
2. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness.
Holtgrave DR
J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
Pinkerton SD; Holtgrave DR; Pinkerton HJ
Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of HIV counseling-and-testing services: making the most of limited resources.
Holtgrave DR; Reiser WJ; Di Franceisco W
AIDS Educ Prev; 1997 Jun; 9(3 Suppl):105-18. PubMed ID: 9241402
[TBL] [Abstract][Full Text] [Related]
5. National HIV Testing Day at CDC-funded HIV counseling, testing, and referral sites--United States, 1994-1998.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jun; 49(24):529-32. PubMed ID: 10923852
[TBL] [Abstract][Full Text] [Related]
6. HIV prevention community planning and communities of color: do resources track the epidemic?
Holtgrave DR; Thomas CW; Chen H; Edlavitch S; Pinkerton SD; Fleming P
AIDS Public Policy J; 2000; 15(2):75-81. PubMed ID: 11519369
[TBL] [Abstract][Full Text] [Related]
7. Costs and consequences of the US Centers for Disease Control and Prevention's recommendations for opt-out HIV testing.
Holtgrave DR
PLoS Med; 2007 Jun; 4(6):e194. PubMed ID: 17564488
[TBL] [Abstract][Full Text] [Related]
8. Prevention of HIV infection in drug abusers: a cost analysis.
Gorsky RD; MacGowan RJ; Swanson NM; DelGado BP
Prev Med; 1995 Jan; 24(1):3-8. PubMed ID: 7740013
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of HIV partner counseling and referral services using new disposition codes.
Golden MR; Stekler J; Kent JB; Hughes JP; Wood RW
Sex Transm Dis; 2009 Feb; 36(2):95-101. PubMed ID: 19131906
[TBL] [Abstract][Full Text] [Related]
10. Publicly funded HIV counseling and testing--United States, 1991.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Aug; 41(34):613-7. PubMed ID: 1501603
[TBL] [Abstract][Full Text] [Related]
11. Anonymous or confidential HIV counseling and voluntary testing in federally funded testing sites--United States, 1995-1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1999 Jun; 48(24):509-13. PubMed ID: 10401907
[TBL] [Abstract][Full Text] [Related]
12. Economic and demographic consequences of AIDS in Namibia: rapid assessment of the costs.
Ojo K; Delaney M
Int J Health Plann Manage; 1997; 12(4):315-26. PubMed ID: 10177418
[TBL] [Abstract][Full Text] [Related]
13. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India.
Dandona L; Sisodia P; Ramesh YK; Kumar SG; Kumar AA; Rao MC; Someshwar M; Hansl B; Marshall N; Marseille E; Kahn JG
Natl Med J India; 2005; 18(1):26-31. PubMed ID: 15835489
[TBL] [Abstract][Full Text] [Related]
14. Publicly funded HIV counseling and testing--United States, 1990.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(39):666-9, 675. PubMed ID: 1654500
[TBL] [Abstract][Full Text] [Related]
15. Publicly funded HIV counseling and testing--United States, 1985-1989.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1990 Mar; 39(9):137-40. PubMed ID: 2154664
[No Abstract] [Full Text] [Related]
16. Partner counseling and referral services to identify persons with undiagnosed HIV--North Carolina, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Dec; 52(48):1181-4. PubMed ID: 14654767
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
Kim SY; Billah K; Lieu TA; Weinstein MC
Am J Prev Med; 2006 Jun; 30(6):498-506. PubMed ID: 16704944
[TBL] [Abstract][Full Text] [Related]
18. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
Abramowitz S; Greene D
AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
[TBL] [Abstract][Full Text] [Related]
19. Estimated effectiveness and cost-effectiveness of federally funded prevention efforts on gonorrhea rates in the United States, 1971-2003, under various assumptions about the impact of prevention funding.
Chesson HW
Sex Transm Dis; 2006 Oct; 33(10 Suppl):S140-4. PubMed ID: 16505737
[TBL] [Abstract][Full Text] [Related]
20. Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991.
Scitovsky AA; Rice DP
J Med Pract Manage; 1988; 3(4):234-41. PubMed ID: 10314299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
